ALL YOU NEED TO KNOW ABOUT “QUVIVIQ” (DARIDOREXANT): THE NEW INSOMNIA TREATMENT
Studies show that 10%-30% of people worldwide don’t get enough sleep. In some populations, the percentage of people with insomnia is as high as 50%-60%. Quviviq (daridorexant) is a newly approved drug to treat insomnia in adults. It’s a dual orexin receptor antagonist that blocks wake-promoting neurotransmitters and promotes sleep. |
|
